- Home
- ICLR vs FIG Comparison
ICLR vs FIG Comparison
Compare ICLR & FIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICLR | FIG |
|---|---|---|
| Founded | 1990 | 2012 |
| Country | Ireland | United States |
| Employees | N/A | 1886 |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 10.6B |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | ICLR | FIG |
|---|---|---|
| Price | $116.30 | $22.69 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 13 |
| Target Price | ★ $178.62 | $50.50 |
| AVG Volume (30 Days) | 1.3M | ★ 17.8M |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $31.18 |
| Revenue Next Year | N/A | $20.22 |
| P/E Ratio | $12.91 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $66.57 | $16.60 |
| 52 Week High | $211.00 | $114.29 |
Technical Indicators
Market Signals| Indicator | ICLR | FIG |
|---|---|---|
| Relative Strength Index (RSI) | 50.50 | 57.77 |
| Support Level | $99.11 | $17.59 |
| Resistance Level | $121.03 | $23.15 |
| Average True Range (ATR) | 6.15 | 1.49 |
| MACD | -0.64 | 0.42 |
| Stochastic Oscillator | 32.51 | 56.04 |
Price Performance
Historical ComparisonAbout ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
About FIG Figma Inc.
Figma Inc is engaged in transforming ideas into digital products and experiences. The group focuses on the entire software creation lifecycle, enabling it to quickly launch new products on Figma's browser-based platform and reinforcing its belief that design extends well beyond a single step or role. The company adopts an expansive view, as design is more than how something looks, feels, or works. It derives its revenue from sales of subscriptions for access to its platform.